Tag: Express Scripts

Pharmacy Everywhere: Express Scripts and MedAvail announce collaboration to make pharmacy more affordable and convenient

Convenience is the new currency among consumers looking for faster, easier, always-accessible services to conform to their daily lives.  As a result, the economy’s next big evolution may impact how tens of millions of people get their prescription drugs. That’s the vision of Express Scripts (NASDAQ: ESRX), which today announced a strategic investment in MedAvail, a leading healthcare technology company behind self-service pharmacy centers. “Technology — and a culture shift — allow us the opportunity to […]

RELEASE: Innovative value-based SafeGuardRx® program delivers better care at lower cost for Express Scripts’ patients and plan sponsors

ST. LOUIS /PRNewswire/ — Express Scripts (NASDAQ: ESRX) released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx® programs. Using available evidence to facilitate the most appropriate and effective treatments, providing high-touch clinical support to help patients manage complex conditions, and value-based payment systems, SafeGuardRx has delivered better medication adherence, higher therapy completion rates, greater compliance with […]

RELEASE: Express Scripts Announces 2018 First Quarter Results

ST. LOUIS, May 2, 2018 /PRNewswire/ — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated 2018 first quarter adjusted earnings per diluted share was $1.77.* The Company reaffirms its core business¹ 2018 adjusted EBITDA* guidance in the range of $5,250 million to $5,400 million, which represents growth of 8% over core business 2017 adjusted EBITDA at the midpoint of the range. “Our first quarter results reflect our success in driving greater […]

RELEASE: Express Scripts Ranked as a Top 50 Inclusive company by DiversityInc

ST. LOUIS, May 2, 2018 /PRNewswire/ — Express Scripts (NASDAQ: ESRX), through its commitment to diversity and inclusion, has earned recognition among the Top 50 inclusive companies in the nation by DiversityInc, it was announced today. “We are proud to be recognized by DiversityInc for creating a culture which celebrates the unique talents, values and perspectives contributed by every one of our more than 27,000 colleagues,” said Tim Wentworth, Express Scripts president and CEO. “Our diversity makes Express Scripts […]

RELEASE: “Knowing But Not Doing: The State of Rx Adherence in America Report” Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications

ST. LOUIS, April 25, 2018 /PRNewswire/ — Many Americans on medications for chronic diseases are not concerned about missing doses, resent their spouses/partners reminding them to take their medicine and think they do a better job than others at taking their medication as prescribed. That’s according to a new survey, Knowing But Not Doing: The State of Rx Adherence in America Report from Express Scripts (NASDAQ: ESRX). The survey found that nearly one-third of those taking prescription medications for […]

Express Scripts names Mike Cirillo president of myMatrixx

Express Scripts has announced on Monday that Mike Cirillo will be named the new president of myMatrixx, a pharmacy benefits solutions provider for the massive pharmaceutical company. According to the company, Cirillo will replace Artemis Emslie, who will stay with myMatrixx until the end of May to assist with the transition. Cirillo’s main role within myMatrixx is to ensure that the strategic direction of the company is set, and to help myMatrixx grow the business […]

RELEASE: Express Scripts endorses “Know the Lowest Price Act of 2018” and “Patient Right to Know Drug Prices Act”

ST. LOUIS /PRNewswire/ — Express Scripts (NASDAQ:ESRX) today released this statement in support of S. 2553, the “Know the Lowest Price Act of 2018,” introduced by U.S. Senators Stabenow, Collins, Wyden, Cassidy, McCaskill and Barrasso, and S. 2554, the “Patient Right to Know Drug Prices Act,” introduced by U.S. Senators Collins, McCaskill, Barrasso, Stabenow and Cassidy. Express Scripts is against clawbacks and gag clauses, anti-patient practices that have been used by other pharmacy benefit managers. “Express […]

RELEASE: Express Scripts Holding Company to Cancel Investor Day Meeting

ST. LOUIS, March 14, 2018 /PRNewswire/ — Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts“) announced today it cancelled its previously announced investor day meeting, which was scheduled to be held in New York Cityon May 2, 2018, at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) at The Roosevelt Hotel New York.  The cancellation is due to the recent announcement that Cigna and Express Scripts have entered into an Agreement and Plan of Merger. About Express Scripts Express Scripts is […]

RELEASE: Express Scripts awarded national recognition for fighting the opioid epidemic

ST. LOUIS /PRNewswire/ — On Tuesday, Express Scripts (NASDAQ: ESRX) was awarded the Pharmacy Benefit Management Institute’s (PBMI) Excellence Award in the Opioid Management Strategy Category.  The award comes in recognition of the ground breaking ways Express Scripts is helping plan sponsors fight  the serious dangers of opioid misuse and abuse. “PBMI’s recognition of our mission-driven work is validation that we are able to make a real difference in getting patients on a path toward safer […]

RELEASE: Express Scripts Holding Company Announces Webcast of Investor Day Meeting

ST. LOUIS, Feb. 21, 2018 /PRNewswire/ — Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts“) announced today it has scheduled an investor day meeting in New York City on May 2, 2018, at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) at The Roosevelt Hotel New York.  At the meeting, senior leaders will discuss the Company’s future outlook, its strategy of creating value for patients and clients and how its innovative tools and solutions position the Company for the future of healthcare. […]